1. Deoxycholic acid activates the c-Jun N-terminal kinase pathway via FAS receptor activation in primary hepatocytes. Role of acidic sphingomyelinase-mediated ceramide generation in FAS receptor activation.
- Author
-
Gupta S, Natarajan R, Payne SG, Studer EJ, Spiegel S, Dent P, and Hylemon PB
- Subjects
- Alleles, Animals, Bile Acids and Salts metabolism, Brefeldin A pharmacology, Cells, Cultured, Ceramides metabolism, Cholesterol 7-alpha-Hydroxylase biosynthesis, Cholesterol 7-alpha-Hydroxylase metabolism, Down-Regulation, Enzyme Activation, Enzyme Inhibitors pharmacology, ErbB Receptors metabolism, Free Radicals, JNK Mitogen-Activated Protein Kinases, Ligands, MAP Kinase Kinase 4, Mice, Mice, Inbred C57BL, Mice, Knockout, Mice, Transgenic, Microscopy, Fluorescence, Mitogen-Activated Protein Kinase Kinases metabolism, Protein-Tyrosine Kinases antagonists & inhibitors, RNA, Messenger metabolism, Rats, Time Factors, Tumor Necrosis Factor-alpha metabolism, Deoxycholic Acid metabolism, Hepatocytes metabolism, Mitogen-Activated Protein Kinases metabolism, Sphingomyelin Phosphodiesterase metabolism, fas Receptor metabolism
- Abstract
We have shown previously that bile acids can activate the JNK pathway and down-regulate cholesterol 7alpha-hydroxylase (CYP7A1), the rate-limiting enzyme in the neutral pathway of bile acid biosynthesis. In this study, the mechanism(s) by which deoxycholic acid (DCA) activates the JNK pathway were examined. FAS receptor (FAS-R) and acidic sphingomyelinase (ASM)-deficient hepatocytes were resistant to DCA-induced activation of the JNK pathway. Activation of the JNK pathway (2-3-fold) in response to tumor necrosis factor-alpha was similar in both wild-type and FAS-R(-/-) hepatocytes. In wild-type and FAS-R(-/-) hepatocytes, ceramide elevation was detected as early as 2 min and peaked at 10 min after DCA treatment. In contrast, ASM(-/-) hepatocytes were defective in DCA-induced ceramide generation. Treatment with DCA resulted in movement of FAS-R to the cell surface, which was blocked upon treatment with brefeldin A. However, brefeldin A failed to block DCA-mediated JNK activation in wild-type hepatocytes. DCA-induced JNK activation was independent of either the epidermal growth factor receptor activation or free radical generation. Addition of ASM to rat hepatocytes activated JNK and down-regulated CYP7A1 mRNA levels. In conclusion, these results show that DCA activates JNK and represses CYP7A1 mRNA levels in primary hepatocytes via an ASM/FAS-R-dependent mechanism that is independent of either the epidermal growth factor receptor or free radical generation. more...
- Published
- 2004
- Full Text
- View/download PDF